Meningococcal Infection: Clinical Trials

9 trials for Meningococcal Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 1 recruiting. 9 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 39Completed 8, Recruiting 1

Follow Meningococcal Infection: new trials by email Literature Review of Meningococcal Infection trials Research Report on Meningococcal Infection

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Infants and Toddlers in China
MenQuadfi® (Meningococcal Polysaccharide [Serogroups A, C, W, and Y] Tetanus Toxoid Conjugate Vaccine) (Sanofi Pasteur Inc., Swiftwater, PA, USA), Menhycia® (ACYW135 Meningococcal Conjugate Vaccine [CRM197]) (CanSino Biologics Inc., China) - Meningococcal Infection, Healthy Volunteers
Phase 3RecruitingSanofi45682026-08-222026-10-19
Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in China
MenACYW conjugate vaccine, MenACYW135 polysaccharide vaccine, MenAC conjugate vaccine - Meningococcal Infection, Healthy Volunteers
Phase 3CompletedSanofi16022025-09-262026-10-19
Study on a MenACYW Conjugate Vaccine Administered as a Single Dose in Participants Aged 12 Months and Older in Vietnam
Meningococcal Polysaccharide (Serogroups A, C, W, and Y) Tetanus Toxoid Conjugate Vaccine - Meningococcal Infection, Healthy Volunteers
Phase 3CompletedSanofi Pasteur, a Sanofi Company4472024-01-182025-09-17
Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian Federation
Meningococcal Diphtheria Toxoid Vaccine - Meningitis, Meningococcal Infection
Phase 3CompletedSanofi Pasteur, a Sanofi Company3002013-06-252022-04-19
Duration of hSBA Response After a Primary Series of Bivalent rLP2086 Followed by a Booster Dose
blood sampling, bivalent rLP2086 - Meningococcal Infection
Phase 3CompletedPfizer6982012-09-072020-03-27
Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and Toddlers
Meningococcal vaccine GSK 134612, SynflorixTM, Infanrix-IPV/HiberixTM - Meningococcal Infection
Phase 3CompletedGlaxoSmithKline7532012-01-272019-08-06
Study of Two Doses of Menactra® or One Dose of Monovalent Meningococcal Group C Vaccine With Routine Immunizations
Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate: Menactra®, Meningococcal Group C Conjugate vaccine: MenC - Meningitis, Meningococcal Infection
Phase 3CompletedSanofi Pasteur, a Sanofi Company1232011-05-012016-08-19
A Study of Meningococcal Vaccine, Menactra® in Healthy Subjects in India
Meningococcal Polysaccharide Diphtheria Toxoid Conjugate (Menactra®) - Meningococcal Infection, Meningitis
Phase 3CompletedSanofi3002010-06-012012-02-06
Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
MenACWY-CRM197, DTaP (Diptheria, Tetanus, Pertussis) Vaccine, Hib (Haemophilus influenza b) Vaccine - Meningitis, Meningococcal Infection
Phase 3CompletedNovartis77442008-12-012013-07-09

Narrower conditions

Meningococcal Infections (9)  ·  Meningitis (4)  ·  Meningitis, Bacterial (1)

Broader conditions

Bacterial Infections (9)  ·  Bacterial Infections and Mycoses (9)  ·  Gram-Negative Bacterial Infections (9)  ·  Infections (9)  ·  Neisseriaceae Infections (9)  ·  Nervous System Diseases (4)  ·  Neuroinflammatory Diseases (4)  ·  Central Nervous System Bacterial Infections (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Infections (1)

Interventions

Meningococcal Vaccines (3)  ·  Blood Specimen Collection (1)  ·  CRM197 (non-toxic variant of diphtheria toxin) (1)  ·  Chickenpox Vaccine (1)  ·  Hepatitis A Vaccines (1)  ·  Pneumococcal Vaccines (1)  ·  Poliovirus Vaccine, Inactivated (1)  ·  Tetanus Toxoid (1)  ·  Vaccines (1)

Sponsors

Sanofi (3)  ·  Sanofi Pasteur, a Sanofi Company (3)  ·  GlaxoSmithKline (1)  ·  Novartis (1)  ·  Pfizer (1)

Countries

China (3)  ·  India (2)  ·  United States (2)  ·  Canada (1)  ·  Costa Rica (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Finland (1)  ·  Germany (1)  ·  Guatemala (1)  ·  Lebanon (1)  ·  Mexico (1)  ·  Panama (1)  ·  Peru (1)  ·  Russia (1)

Results publications

PMID 25285126, PMID 29784470, PMID 30770221, PMID 42862517